Engelman A - Search Results

1

Characterization of a replication-defective human immunodeficiency virus type 1 att site mutant that is blocked after the 3' processing step of retroviral integration.

Chen H, Engelman A. Chen H, et al. Among authors: engelman a. J Virol. 2000 Sep;74(17):8188-93. doi: 10.1128/jvi.74.17.8188-8193.2000. J Virol. 2000. PMID: 10933731 Free PMC article.

2

Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.

Engelman A, Rosenberg N. Engelman A, et al. J Virol. 1990 Sep;64(9):4242-51. doi: 10.1128/JVI.64.9.4242-4251.1990. J Virol. 1990. PMID: 1696637 Free PMC article.

3

Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.

Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R. Engelman A, et al. J Virol. 1995 May;69(5):2729-36. doi: 10.1128/JVI.69.5.2729-2736.1995. J Virol. 1995. PMID: 7535863 Free PMC article.

4

Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity.

Engelman A, Craigie R. Engelman A, et al. J Virol. 1995 Sep;69(9):5908-11. doi: 10.1128/JVI.69.9.5908-5911.1995. J Virol. 1995. PMID: 7637039 Free PMC article.

5

Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1.

Englund G, Theodore TS, Freed EO, Engelman A, Martin MA. Englund G, et al. Among authors: engelman a. J Virol. 1995 May;69(5):3216-9. doi: 10.1128/JVI.69.5.3216-3219.1995. J Virol. 1995. PMID: 7707554 Free PMC article.

6

An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.

Vicenzi E, Dimitrov DS, Engelman A, Migone TS, Purcell DF, Leonard J, Englund G, Martin MA. Vicenzi E, et al. Among authors: engelman a. J Virol. 1994 Dec;68(12):7879-90. doi: 10.1128/JVI.68.12.7879-7890.1994. J Virol. 1994. PMID: 7966578 Free PMC article.

7

The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding.

Engelman A, Hickman AB, Craigie R. Engelman A, et al. J Virol. 1994 Sep;68(9):5911-7. doi: 10.1128/JVI.68.9.5911-5917.1994. J Virol. 1994. PMID: 8057470 Free PMC article.

8

Biochemical characterization of recombinant equine infectious anemia virus integrase.

Engelman A. Engelman A. Protein Expr Purif. 1996 Nov;8(3):299-304. doi: 10.1006/prep.1996.0104. Protein Expr Purif. 1996. PMID: 8936591

9

Reversion of a human immunodeficiency virus type 1 integrase mutant at a second site restores enzyme function and virus infectivity.

Taddeo B, Carlini F, Verani P, Engelman A. Taddeo B, et al. Among authors: engelman a. J Virol. 1996 Dec;70(12):8277-84. doi: 10.1128/JVI.70.12.8277-8284.1996. J Virol. 1996. PMID: 8970947 Free PMC article.

10

Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase.

Engelman A, Liu Y, Chen H, Farzan M, Dyda F. Engelman A, et al. J Virol. 1997 May;71(5):3507-14. doi: 10.1128/JVI.71.5.3507-3514.1997. J Virol. 1997. PMID: 9094622 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters